William Blair & Company
VIVO

William Blair & Company’s Meridian Bioscience Inc VIVO Stock Holding History

William Blair & Company’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-18,319
Closed -$311K – 1881
2020
Q3 		$311K Buy
18,319
+8,600
+88% +$167K ﹤0.01% 1134
2020
Q2 		$226K Buy
+9,719
New +$141K ﹤0.01% 1193

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company's VIVO Position: Q4 2020 in Review

William Blair & Company sold out of Meridian Bioscience Inc (VIVO) in Q4 2020, closing a stake of 18,319 shares — an estimated $311K sold.

William Blair & Company first reported a position in VIVO in Q2 2020 and held it in 2 quarters. The position peaked at $311K in Q3 2020. 192 funds tracked by Wall St. Rank hold VIVO as of Q4 2020.

  • William Blair & Company reported no remaining Meridian Bioscience Inc position as of Q4 2020 after selling out during the quarter.
  • William Blair & Company sold 18,319 Meridian Bioscience Inc shares in Q4 2020, an estimated $311K.
  • William Blair & Company first reported a position in Meridian Bioscience Inc in Q2 2020 and held it in 2 quarters.
  • William Blair & Company's Meridian Bioscience Inc position peaked at $311K in Q3 2020.
  • 192 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2020.

Based on William Blair & Company's 13F filing for Q4 2020, filed 9 Feb 2021.